Your session is about to expire
← Back to Search
Early Palliative Care for Advanced Cancer
N/A
Waitlist Available
Led By Camilla Zimmermann, MD, PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
ECOG performance status ≤ 2 (estimated by primary oncologist)
Age ≥ 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 and 4 months after enrollment
Awards & highlights
Study Summary
This trial is important as it will provide data on whether earlier referral to palliative care can improve patient outcomes.
Who is the study for?
This trial is for adults over 18 with advanced stage IV cancer, or certain stage III cancers with a poor prognosis. Participants must have an ECOG performance status of ≤2, indicating they can care for themselves but may not be able to carry out work activities, and a life expectancy of more than 6 months.Check my eligibility
What is being tested?
The STEP system is being tested to see if it helps identify patients with severe symptoms early on so they can receive palliative care sooner. This single-arm trial will help plan for a larger study comparing STEP to usual care.See study design
What are the potential side effects?
Since this intervention involves symptom screening and referral to palliative care rather than direct medical treatment, specific side effects are not applicable as in drug trials.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My doctor says I can take care of myself and do some daily activities.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 and 4 months after enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 and 4 months after enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Depression
Patient Heath Related Quality of Life (HRQL) as measured by the FACIT-Sp.
Patient Heath Related Quality of Life (HRQL) as measured by the QUAL-E.
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Symptom screening with Targeted Early Palliative care (STEP)Experimental Treatment1 Intervention
The experimental arm receives routine symptom screening at every outpatient visit; if symptoms are above a certain threshold, then a triggered email is sent to a triage nurse, who calls the patient to offer early referral to and follow-up by a symptom control and palliative care team.
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,465 Previous Clinical Trials
483,589 Total Patients Enrolled
Camilla Zimmermann, MD, PhDPrincipal InvestigatorUniversity Health Network, Toronto
2 Previous Clinical Trials
530 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still available openings for participants in this investigation?
"As the information found on clinicaltrials.gov specifies, this trial is not currently accepting volunteers and has not been updated since April 8th 2022. Nevertheless, there are 485 other medical studies actively recruiting participants right now."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger